New hope for myelofibrosis patients was announced in August 2022, after the acceptance of the new drug application (NDA) for...
Home
Today represents a key milestone for beta-thalassemia patients battling hereditary chronic disease. This comes after the approval that was granted...
During the last three months, the FDA approved several molecules and indications. In May, the following indications were approved: Fam-trastuzumab...
Voxelotor (Oxbryta) is the first hemoglobin oxygen-affinity modulator. It has disease-modifying potential by increasing hemoglobin levels and decreasing hemolysis indicators...
On June 18, 2020, the Food and Drug Administration granted accelerated approval to tazemetostat (TAZVERIK), the first-in-class EZH2 inhibitor. The...
Ipsen announced that it entered into a definitive merger agreement to acquire Epizyme. The acquisition is anticipated to be closed...
Pfizer has agreed to acquire Global Blood Therapeutics for $5.4 billion. Based on this, Global Blood Therapeutics will hand its...
In February 2022, the Food and Drug Administration (FDA) approved nivolumab with platinum-doublet chemotherapy for adult patients with resectable non-small...
What is Sarcoidosis? Sarcoidosis is a rare disease where inflamed cells clump together to make small lumps called granulomas which...
In February 2022, the Food and Drug Administration (FDA) approved ciltacabtagene autoleucel for Janssen Biotech for the treatment of adult...
